Floatz logo

Dilatrend Sr

Chronic Stable Angina

Chong Kun Dang PharmaceuticalPhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

18 Active assets in the Chronic Stable Angina cohort.

Asset / SponsorPhaseRating
Acetylsalicylic Acid
Rajaie Cardiovascular Medical and Research Center
Phase 4BBB
Ezetimibe
Canadian Collaborative Research Network
Phase 4BBB
Ranolazine
OBS Pakistan
Phase 4BBB
SIMVASTATIN
University of Washington
Phase 4BBB
Rivaroxaban
Sheffield Teaching Hospitals NHS Foundation Trust
Phase 4BBB

View all 50 →

Same molecule, other indications

Dilatrend Sr is also rated in:

essential hypertensionDormant
CC
Indicative ·
43 / 100
View asset →
congestive heart failureDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →